Comparing the effects of prescribed safer opioid supply and methadone in Ontario, Canada: a population-based matched cohort study
Gomes T, McCormack D, Kolla G, Young S, Bayoumi A, Smoke A, Li P, Antoniou T. Lancet Public Health. 2025; Apr 22.
Publications
Trends in the cost and utilization of publicly dispensed respiratory inhalers in Ontario, Canada: a repeated cross-sectional study
Garg R, Wang T, Tadrous M, Antoniou T, Gomes T. Pharmacoepidemiol Drug Saf. 2025; 34(4):e70125.
Glucagon-like peptide 1 receptor agonists and risk of thyroid cancer: an international multisite cohort study
Baxter SM, Lund LC, Andersen JH, Brix TH, Hegedüs L, Hsieh MH, Su CT, Cheng MC, Chang ZC, Lai EC, Hussain S, Chu C, Gomes T, Antoniou T, Eskander A, Bouck Z, Tadrous M, Bea S, Choi EY, Shin JY, Modig K, Talbäck M, Ljung R, Gulseth HL, Karlstad Ø, Hicks B, Pottegård A. Thyroid. 2025; 35(1):69-78.
Impact of policy changes expanding access to direct-acting antivirals on hepatitis c virus-related hospitalizations in people with HIV: a population-based study
Antoniou T, Ledlie S, Wang T, Tadrous M, Gomes T. Open Forum Infect Dis. 2025; 12(1):ofaf003.
Associations of CD4 cell count measures with infection-related and infection-unrelated cancer risk among people with HIV
Nicolau IA, Moineddin R, Brooks JD, Antoniou T, Gillis JL, Kendall CE, Cooper C, Cotterchio M, Salters K, Smieja M, Kroch AE, Price C, Mohamed A, Burchell AN. J Acquir Immune Defic Syndr. 2024; 96(5):447-456.
A population-based study of the impact of the COVID-19 pandemic on benzodiazepine use among children and young adults
Antoniou T, Pajer K, Gardner W, Penner M, Lunsky Y, McCormack D, Tadrous M, Mamdani M, Gozdyra P, Juurlink DN, Gomes T. Eur Child Adolesc Psychiatry. 2024; Aug 7 [Epub ahead of print].
Characteristics of opioid toxicity deaths among adolescents and young adults in Ontario prior to and during the COVID-19 pandemic
Akbar S, Iacono A, Yang J, Antoniou T, Juurlink D, Sheikh H, Kurdyak P, Wu F, Cheng C, Leece P, Kolla G, Emblem J, Shearer D, Gomes T. J Adolesc Health. 2024; Apr 9 [Epub ahead of print].
Alpha-1 adrenergic antagonists and the risk of hospitalization or death in non-hospitalized patients with COVID-19: a population-based study
Antoniou T, McCormack D, Tadrous M, Gomes T. Fundam Clin Pharmacol. 2024; Apr 4 [Epub ahead of print].
Impact of COVID-19 pandemic on prescription stimulant use among children and youth: a population-based study
Antoniou T, Pajer K, Gardner W, Penner M, Lunsky Y, McCormack D, Tadrous M, Mamdani M, Gozdyra P, Juurlink DN, Gomes T. Eur Child Adolesc Psychiatry. 2024; Jan 5 [Epub ahead of print].
Opioid agonist treatment retention among people initiating methadone and buprenorphine across diverse demographic and geographic subgroups in Ontario: a population-based retrospective cohort study
Elnagdi A, McCormack D, Bozinoff N, Tadrous M, Antoniou T, Munro C, Campbell T, Paterson JM, Mamdani M, Sproule B, Gomes T. Can J Addict. 2023; 14(4):p 44-54. Epub 2023 Dec 29.